Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
---|
08/11/2005 | US20050175543 Agents for magnetic imaging method |
08/11/2005 | US20050175541 Enhanced drug delivery |
08/10/2005 | EP1561425A1 Indocyanine dyes |
08/10/2005 | EP1084145B1 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use thereof for diagnosis and therapy of tumors and diseases associated with angiogenesis |
08/10/2005 | EP0894009B1 Improved vision through photodynamic therapy of the eye |
08/10/2005 | EP0776175B1 Therapeutic homeopathic dilutions of growth factors and use |
08/10/2005 | CN1652831A Electrocardiographic aspects of CHF treatment |
08/10/2005 | CN1652804A Method for extended storage of blood and blood components |
08/06/2005 | CA2470403A1 Photodynamic therapy for the treatment of hyperactive sebaceous gland disorders |
08/06/2005 | CA2457214A1 Photodynamic therapy for the treatment of acne |
08/04/2005 | WO2005058889A3 Biological active blood serum obtained by electrostimulation |
08/04/2005 | WO2005051305A3 Enhanced drug delivery |
08/04/2005 | WO2005037259A3 Methods and compositions for the prevention or treatment of neoplasia comprising a cox-2 inhibitor in combination with an epidermal growth factor receptor antagonist |
08/04/2005 | US20050169944 Administering ozone to reduce hypoxia; enhancing drug or radio therapy |
08/03/2005 | EP1559374A1 Cyanine dyes |
08/03/2005 | EP1558616A2 Meso-substituted porphyrins |
08/03/2005 | EP1359975A4 Ocular iontophoretic device and method of use |
08/03/2005 | EP0702719B1 Process for the sterilization of biological compositions and the product produced thereby |
08/03/2005 | CN1649585A Epothilone derivative for the treatment of hepatoma and other cancer diseases |
08/03/2005 | CN1649584A Antibacterial compositions comprising metal phthalocyanine analogues |
08/03/2005 | CN1649583A Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy |
08/02/2005 | US6924284 PARP inhibitors |
08/02/2005 | US6923955 Prophylaxis and/or reversing presbyopia by applying localized energy to area to be treated and administering biologically acceptable chemical substance capable of breaking chemical bonds such as disulfide bonds between cortical lens fibers |
07/28/2005 | WO2004080284A9 Antibody-targeted photodynamic therapy |
07/28/2005 | US20050165393 Microporation of tissue for delivery of bioactive agents |
07/28/2005 | US20050163778 Extracorporeal photopheresis in combination with anti-TNF treatment |
07/28/2005 | US20050163716 Methods of preparing gaseous precursor-filled microspheres |
07/27/2005 | EP1556061A2 Photokinetic delivery of biologically active substances using pulsed incoherent light |
07/27/2005 | EP1555948A2 Phototreatment device for use with coolants and topical substances |
07/27/2005 | EP0935462B1 Photopheresis treatment of leukocytes |
07/27/2005 | CN2712931Y Electromagnetic cleavage device for cleavage extracting polypeptide from vegetable protein |
07/27/2005 | CN1646174A Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier |
07/27/2005 | CN1646164A Process for the preparation of a nutrient formulation |
07/27/2005 | CN1646097A Chemosensitizing with liposomes containing oligonucleotides |
07/26/2005 | US6922578 Integrated poration, harvesting and analysis device, and method therefor |
07/21/2005 | WO2005065282A2 Remote magnetically induced treatment of cancer |
07/21/2005 | US20050159401 Treating atheroma, tumors and other neoplastic tissue; treating atherosclerotic inflammation; forming a complexes with a reducing agent, penetrate and accumulate more rapidly in tumor cells, plaque, increase drug in intracellular concentration; increase photosensitivity |
07/21/2005 | US20050158290 Process for the preparation of a nutrient formulation |
07/21/2005 | US20050156147 Two-photon polymerizable composition and process for polymerization thereof |
07/20/2005 | CN1211127C Nanoscale particles having iron oxide-containing core enveloped by at least two shells |
07/19/2005 | US6919327 Texaphyrin coordination compounds and uses thereof |
07/19/2005 | US6919179 Generating labeled proteins; obtain nucleotide sequences, incubate with cell free translation system, recover labeled protein |
07/14/2005 | WO2005063306A1 Assembly of gas-filled microvesicle with active component for contrast imaging |
07/14/2005 | WO2005063305A1 Gas-filled microvesicle assembly for contrast imaging |
07/14/2005 | WO2005034855A3 Photodynamic inactivation of bacterial spores |
07/14/2005 | US20050154049 Administering an ultrasonic contrast agent; imaging tissue; medical diagnosis |
07/14/2005 | US20050153961 to hypoxic tumor cells and aerobic cells following or preceding a hypoxic incubation of the cells with the drug; ability to kill hypoxic cells directly; in vitro and in vivo; substitution in position 3 determines desired activity for compound |
07/14/2005 | US20050152960 Photodynamic therapy; age-related macular degeneration; liposomes |
07/14/2005 | CA2547024A1 Gas-filled microvesicle assembly for contrast imaging |
07/14/2005 | CA2545362A1 Assembly of gas-filled microvesicle with active component for contrast imaging |
07/13/2005 | EP1551461A2 Azo compounds for type i phototherapy |
07/13/2005 | EP1551454A1 Protein production |
07/13/2005 | CN1639178A Novel, water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases |
07/13/2005 | CN1639154A Pyranones useful as ATM inhibitors |
07/13/2005 | CN1210020C Use of biodegradable microspheres for delivery of anticancer for treatment of glioblastoma |
07/12/2005 | US6916810 αν integrin receptor antagonists |
07/12/2005 | US6916800 Gelatinase inhibitors; anticancer agents |
07/07/2005 | WO2005061518A1 Mitotic kinesin inhibitors |
07/07/2005 | WO2005030253A3 Photocleavable dna transfer agent |
07/07/2005 | US20050148772 Methods and compositions for detecting polynucleotide duplex damage and errors |
07/07/2005 | DE10346950A1 Four-component herbal composition in form of capsules, useful for long-term, pre- or post-operative treatment of malignant tumors |
07/07/2005 | CA2551543A1 Method of suppressing cancer |
07/07/2005 | CA2547746A1 Mitotic kinesin inhibitors |
07/06/2005 | EP1550454A1 Extracorporeal photopheresis in combination with anti-TNF treatment |
07/06/2005 | EP1549320A1 Therapeutic combinations of erb b kinase inhibitors and antineoplastic therapies |
07/06/2005 | EP1490315A4 Controlling chemical reactions by spectral chemistry and spectral conditioning |
07/06/2005 | EP1044001B1 Integrin receptor antagonists |
07/06/2005 | CN1635907A Topical compositions and methods for treatment of adverse effects of ionizing radiation |
07/06/2005 | CN1635878A Methods of treating cancer and the pain associated therewith with using endothelin antagonists |
07/06/2005 | CN1209172C Method for providing cosmetic/medical therapy |
07/05/2005 | US6914078 Triarylmethane derivatives and their use as photochemotherapeutic agents |
07/05/2005 | US6913914 Yeast culture capable of normalizing serum glutamate-pyruvate transaminase (GPT) and/or reducing serum hepatitis b surface antigen concentration for treating and preventing viral diseases; dietetics |
07/05/2005 | US6913913 Methods and compositions for treating renal failure |
06/30/2005 | WO2005059118A2 Stem cell targeting using magnetic particles |
06/30/2005 | WO2005058889A2 Biological active blood serum obtained by electrostimulation |
06/30/2005 | WO2005058360A2 Radiation therapy and medical imaging using uv emitting nanoparticles |
06/30/2005 | WO2005025508A3 Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents |
06/30/2005 | WO2004112590A3 Methods of enhancing radiation effects with metal nanoparticles |
06/30/2005 | US20050143466 drug delivery to infiltrate into spaces in skin; exposing skin to light energy to cause photosensitizing agent to become photodynamically activated; sebaceous gland disorder, sebum secretion, skin disorders |
06/30/2005 | US20050143406 Use of e.g. 2-butylamino-2-demethoxy-hypocrellin B in sonodyamic therapy to treat cancer, skin disorders, infections, autoimmune diseases |
06/30/2005 | US20050143315 N-[5-[[[5-[[[2-[(aminoiminomethyl)amino]ethyl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]-4-[[[4-[(2-bromo-1-oxo-2-propenyl)amino]-1-methyl-1H-pyrrol-2-yl]carbonyl]amino]-1-methyl-1H-pyrrole-2-carboxamide hydrochloride having radiosensitisation activity |
06/30/2005 | US20050142210 Thrombolytic agents and methods of treatment for thrombosis |
06/30/2005 | US20050139485 applying a resonance conditioning frequencies, spectral energy pattern to a battery cell reaction system, act to accelerate and catalysis the reaction |
06/30/2005 | CA2550084A1 Stem cell targeting using magnetic particles |
06/30/2005 | CA2546979A1 A biological active blood serum, methods of producing it and uses thereof |
06/29/2005 | EP1546203A2 Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof |
06/29/2005 | EP1546168A2 Photoactivated anti-viral and anti-cancer agent |
06/29/2005 | EP1545705A2 Flexible and/or elastic brachytherapy seed or strand |
06/29/2005 | CN1633437A Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic |
06/28/2005 | US6911771 Coatings for low pressure discharge lamps comprising polysiloxanes embedded with glowing flakes, having heat resistance and flexibility |
06/23/2005 | WO2005056058A2 Radiosensitizer conjugate to improve the efficacy of radiolabeled drugs |
06/23/2005 | WO2005030254A3 Conjugates for photodynamic therapy |
06/23/2005 | US20050137207 Inhibitor of prenylprotein tranferase for cancer and tumor treatment |
06/23/2005 | US20050137180 Porphrins or azaporprins for photosensitizing therapy or photodetection with azaporprins for cardiovascular disorders and coordination with metals |
06/23/2005 | US20050136102 Enhanced transport using membrane disruptive agents |
06/23/2005 | CA2546057A1 Method to improve the efficacy of therapeutic radiolabeled drugs |
06/23/2005 | CA2490218A1 Extracorporeal photopheresis in combination with anti-tnf treatment |
06/22/2005 | EP1543119A2 Methods of inhibiting hiv-1 vpr activity and hiv-1 infectivity using atr or rad17 inhibitors |
06/22/2005 | EP1381611B1 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic |
06/22/2005 | EP1272200B1 Divided dose therapies with vascular damaging activity |